In February 2006, local newspapers in the United Kingdom reported on disciplinary judgments made by the Association of the British Pharmaceutical Industry (ABPI) against four pharmaceutical manufacturers. The disciplinary judgments consisted of public reprimands for three companies, and suspension from the association for a period of at least six months for the fourth company.